[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

JPH0788376B2 - Process for producing optically active α-tocotrienol - Google Patents

Process for producing optically active α-tocotrienol

Info

Publication number
JPH0788376B2
JPH0788376B2 JP20653286A JP20653286A JPH0788376B2 JP H0788376 B2 JPH0788376 B2 JP H0788376B2 JP 20653286 A JP20653286 A JP 20653286A JP 20653286 A JP20653286 A JP 20653286A JP H0788376 B2 JPH0788376 B2 JP H0788376B2
Authority
JP
Japan
Prior art keywords
compound
formula
structural formula
represented
tocotrienol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP20653286A
Other languages
Japanese (ja)
Other versions
JPS6363674A (en
Inventor
菊正 佐藤
統 宮本
誠一 井上
周一 佐藤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai Co Ltd
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Priority to JP20653286A priority Critical patent/JPH0788376B2/en
Publication of JPS6363674A publication Critical patent/JPS6363674A/en
Publication of JPH0788376B2 publication Critical patent/JPH0788376B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Pyrane Compounds (AREA)

Description

【発明の詳細な説明】 〔産業上の利用分野〕 本発明は、工業的に有用な光学活性α−トコトリエノー
ルの新規な製造方法に関する。
TECHNICAL FIELD The present invention relates to a novel method for industrially useful production of optically active α-tocotrienol.

〔従来の技術及び問題点〕[Conventional technology and problems]

トコトリエノールはビタミンE同族体の一つであり、近
年その作用が注目されている。トコトリエノールはトコ
フェロールと同様にα,β,γ,δの4種類が知られて
いるが、これらのうちα−トコトリエノールが最も重要
である。
Tocotrienol is one of the vitamin E homologues, and its action has recently attracted attention. Similar to tocopherol, four types of α, β, γ, δ are known as tocotrienols, but α-tocotrienol is the most important of these.

このα−トコトリエノールの中で、天然型の光学活性d
−α−トコトリエノールは下記の構造式(I)を有して
いるが、 この構造式から明らかな如く、クロマン環の2位の位置
に不斉炭素を有していることから、従来光学活性d−α
−トコトリエノールを合成的に得ることは困難であっ
た。
Among these α-tocotrienols, the naturally-occurring optically active d
-Α-tocotrienol has the following structural formula (I), As is clear from this structural formula, since it has an asymmetric carbon atom at the 2-position of the chroman ring, it has conventionally been optically active d-α.
-It was difficult to obtain tocotrienols synthetically.

〔問題点を解決するための手段〕[Means for solving problems]

そこで本発明者等は、光学活性d−α−トコトリエノー
ルを合成的に得る方法について長年研究を重ねた結果、
次に示す方法によりこのことが可能であることを見出
し、ここに本発明を完成するに至った。
Therefore, the present inventors have conducted many years of research on a method for synthetically obtaining optically active d-α-tocotrienol, and as a result,
The inventors have found that this is possible by the method shown below, and have completed the present invention.

即ち本発明は、 構造式: (式中R1は式 で表される基を意味する) で表されるゲラニルゲラニオールをエナンシオセレクテ
ィブ・オキシデーション(enantio−selective oxidati
on)を行い、 構造式: で表されるエポキシ体を得、次いで該化合物を還元的に
開裂せしめ、 構造式: で示される化合物を得、次いで該化合物をトシル化し
て、 構造式: 〔式中Tsはトシル基 を表す。以下同様〕 で表される化合物を得、次いで該化合物を金属ナトリウ
ムの存在下イソプロピルメルカプタンと反応させて、 構造式: で表される化合物を得、次いで該化合物をアセチル化し
て、 構造式: (式中Acはアセチル基を示す。以下同様) で表される化合物を得、次いで該化合物を4−アセトキ
シ−2,3,5−トリメチルフェノールと反応させて、 構造式: で表される化合物を得、次いで該化合物をラネーニッケ
ルと反応させ、更に脱アセチル化して、 構造式: で表される化合物を得、次いで該化合物を直接環化せし
めるか、又は酸化してキノン体を得た後に環化せしめる
ことを特徴とする、 構造式: で表される光学活性d−α−トコトリエノールの製造方
法に係るものである。
That is, the present invention has the structural formula: (Where R 1 is the formula The geranylgeraniol represented by is represented by the enantio-selective oxidati
on) and the structural formula: An epoxy compound represented by the following formula is obtained, and then the compound is reductively cleaved to obtain a structural formula: A compound represented by the formula: [In the formula, Ts is a tosyl group Represents The same applies to the following], and then the compound is reacted with isopropyl mercaptan in the presence of metallic sodium to give a structural formula: A compound represented by the following formula is obtained, and then the compound is acetylated to obtain the structural formula: (Wherein Ac represents an acetyl group; the same applies hereinafter), and then the compound is reacted with 4-acetoxy-2,3,5-trimethylphenol to give a structural formula: A compound represented by the following formula is obtained, and then the compound is reacted with Raney nickel and further deacetylated to obtain a structural formula: The compound represented by the formula (1) is obtained, and then the compound is directly cyclized, or is oxidized to obtain a quinone body and then cyclized, and the structural formula: The present invention relates to a method for producing an optically active d-α-tocotrienol represented by

本発明の合成方法の大略を図解すれば次の通りである。The outline of the synthesis method of the present invention is as follows.

各工程を更に詳しく説明すれば以下の通りである。 Each step will be described in more detail below.

(第1工程) ゲラニルゲラニオールにエナンシオセレクティブ・オキ
シデーションの操作を行い、2,3−エポキシ体を得る。
(Step 1) Geranylgeraniol is subjected to an enantioselective oxidation operation to obtain a 2,3-epoxy compound.

具体的な方法の一例を示せば、ジクロロエタン、トリク
ロロエタンなどのハロゲン系炭化水素中で、ゲラニルゲ
ラニオール、酒石酸ジエステル体、オルトチタン酸テト
ライソプロピル、及びt−ブチルハイドロパーオキサイ
ドを−70〜30℃の温度で酸化を行う。酒石酸エステル体
としては、例えば酒石酸ジエチル、酒石酸ジメチルなど
が利用できる。
If an example of a specific method is shown, geranylgeraniol, a tartaric acid diester, tetraisopropyl orthotitanate, and t-butyl hydroperoxide are heated at a temperature of −70 to 30 ° C. in a halogen-based hydrocarbon such as dichloroethane or trichloroethane. To oxidize. As the tartrate ester, for example, diethyl tartrate, dimethyl tartrate or the like can be used.

(第2工程) 2,3−エポキシ体を還元的に開裂せしめ化合物(IV)を
得る工程である。還元的に開裂せしめるには、例えば水
素化アルミニウムリチウムを用いれば好結果が得られ
る。この際溶媒としては、例えばジエチルエーテル、テ
トラヒドロフランなどのエーテル系溶媒を用い、温度は
特に限定されないが、通常は約−10℃〜40℃において反
応を行う。
(Second step) This is a step of reductively cleaving the 2,3-epoxy compound to obtain the compound (IV). For reductive cleavage, good results can be obtained by using, for example, lithium aluminum hydride. At this time, an ether solvent such as diethyl ether or tetrahydrofuran is used as a solvent, and the temperature is not particularly limited, but the reaction is usually performed at about -10 ° C to 40 ° C.

(第3工程) 本工程は、化合物(IV)をトシル化し化合物(V)を得
る工程である。通常の方法は、ピリジンなどの存在下、
p−トルエンスルホニルクロリドを添加して反応を行
う。
(Third Step) This step is a step of tosylating compound (IV) to obtain compound (V). The usual method is in the presence of pyridine, etc.
The reaction is carried out by adding p-toluenesulfonyl chloride.

(第4工程) 本工程は、第3工程で得られた化合物(V)に金属ナト
リウムの存在下、イゾプロピルメルカプタンを添加して
スルフィドを得る工程である。
(Fourth Step) This step is a step of adding isopropylmercaptan to the compound (V) obtained in the third step in the presence of metallic sodium to obtain a sulfide.

(第5工程) アセチル化工程であり、例えば無水酢酸などのアセチル
化剤によりアセチル化する。
(Fifth Step) In the acetylation step, acetylation is performed with an acetylating agent such as acetic anhydride.

(第6工程) 本工程は、第5工程で得られた化合物(VII)に、4−
アセトキシ−2,3,5−トリメチルフェノールを反応させ
る工程である。
(Sixth Step) In this step, the compound (VII) obtained in the fifth step is treated with 4-
This is a step of reacting acetoxy-2,3,5-trimethylphenol.

(第7工程) 本工程は、第6工程で得られた化合物(IX)のイソプロ
ピルチオ基の除去と脱アセチル化を行う工程である。本
工程はラネーニッケルなどを用いて還元的に脱硫し、水
素化アルミニウムリチウムなどを用いて還元的にアセチ
ル基を除去する方法などで行う。
(Seventh Step) This step is a step of removing the isopropylthio group and deacetylating the compound (IX) obtained in the sixth step. This step is performed by a method such as reductively desulfurizing with Raney nickel or the like and reductively removing the acetyl group with lithium aluminum hydride or the like.

(第8工程) 本工程は、最終目的物質である光学活性d−α−トコト
リエノール(I)を得る工程である。具体的には第7工
程で得られた化合物(X)をp−トルエンスルホン酸、
無水塩化亜鉛などを用いて直接環化せしめるか、又は酸
化して、 構造式: で表されるキノン体を得た後に、例えばパラジウム/炭
素触媒及びp−トルエンスルホン酸或いは無水塩化亜鉛
等により環化せしめることにより行う。
(Eighth Step) This step is a step of obtaining optically active d-α-tocotrienol (I) as a final target substance. Specifically, the compound (X) obtained in the seventh step is treated with p-toluenesulfonic acid,
Cyclization is carried out directly using anhydrous zinc chloride or the like, or by oxidation to give the structural formula: After the quinone compound represented by the formula (1) is obtained, it is cyclized with, for example, a palladium / carbon catalyst and p-toluenesulfonic acid or anhydrous zinc chloride.

酸化工程に用いる酸化剤としては、例えば二酸化鉛、酸
化銀、過酸化水素、フレミー塩などを挙げることができ
るが、要するにヒドロキノン体をキノン体としうるよう
な酸化剤であればいかなるものでも使用可能である。
Examples of the oxidizing agent used in the oxidizing step include lead dioxide, silver oxide, hydrogen peroxide, and Flemmy's salt. In short, any oxidizing agent capable of converting a hydroquinone form to a quinone form can be used. Is.

〔発明の効果〕〔The invention's effect〕

本発明方法は、dl分割を必要とせず、工業的に高収率で
天然型の光学活性α−トコトリエノールを製造できる方
法であり、従って本発明の価値は極めて高いものであ
る。
The method of the present invention is a method which can industrially produce a naturally-occurring optically active α-tocotrienol in a high yield without requiring dl resolution, and therefore the value of the present invention is extremely high.

〔実 施 例〕〔Example〕

以下に実施例を掲げるが、本発明がそれのみに限定され
ることがないことはいうまでもないことである。
Examples will be given below, but it goes without saying that the present invention is not limited thereto.

実施例 1 (2R,3R)−2,3−エポキシゲラニルゲラニオールの合成 D−(−)−酒石酸ジメチル1.80g(10mmol)を塩化メ
チレン110mlに溶かし、−20℃に冷却した。オルトチタ
ン酸テトライソプロピル2.84g(10mmol)を加え10分間
撹拌した後、ゲラニルゲラニオール2.90g(10mmol)を
加えた。tert−ブチルハイドロパーオキサイドの1,2−
ジクロロエタン溶液(3.35M)5.97ml(1.80g,20mmol)
を30分間で滴下し、3時間撹拌した。10%L−(+)−
酒石酸水溶液250mlを加え、ドライアイス−四塩化炭素
浴による冷却を続けたまま30分間撹拌し、浴を外してか
ら、更に2.5時間撹拌を続けた。分液、抽出、乾燥後、
濃縮したら結晶が析出した。濾過、洗浄後、母液を濃縮
し、シリカゲルカラムクロマトグラフィーにより精製し
て(2R,3R)−2,3−エポキシゲラニルゲラニオール2.89
g(Y=94%)を得た。
Example 1 Synthesis of (2R, 3R) -2,3-epoxygeranylgeraniol 1.80 g (10 mmol) of dimethyl D-(-)-tartrate was dissolved in 110 ml of methylene chloride and cooled to -20 ° C. 2.84 g (10 mmol) of tetraisopropyl orthotitanate was added and stirred for 10 minutes, and then 2.90 g (10 mmol) of geranylgeraniol was added. tert-Butyl hydroperoxide 1,2-
Dichloroethane solution (3.35M) 5.97ml (1.80g, 20mmol)
Was added dropwise over 30 minutes and stirred for 3 hours. 10% L-(+)-
250 ml of an aqueous tartaric acid solution was added, and the mixture was stirred for 30 minutes while continuing cooling with a dry ice-carbon tetrachloride bath. After removing the bath, stirring was continued for another 2.5 hours. After separation, extraction and drying,
Crystals precipitated upon concentration. After filtration and washing, the mother liquor was concentrated and purified by silica gel column chromatography to obtain (2R, 3R) -2,3-epoxygeranylgeraniol 2.89.
g (Y = 94%) was obtained.

〔α〕D 17=+4.81゜(C=2.9,CHCl3),95%eenD 25
1.4887 ir(neat)cm-1:3400,2910,2850,1660,1440,1380,1025,
8501 Hnmr(CCl4)δ:1.23(3H,s),1.57(9H,s),1.65(3
H,s),1.81〜2.22(12H,m),2.84(1H,t,J=5.4Hz),3.
60(2H,d,J=5.4Hz),3.92(1H,s),4.77〜5.23(3H,b
m)13 Cnmr(CDCl3)δ:15.71(2C),16.46,17.33,23.29,2
5.35,26.32(2C),26.54,38.35,39.44(2C),60.89,63.
05,123.08,123.84,124.16,130.66,134.56,135.22 実施例 2 (3R)−3,7,11,15−テトラメチルヘキサデカ−6,10,14
−トリエン−1,3−ジオールの合成 側管付き滴下ロート、アリーン冷却管、窒素球を備えた
500cc三ツ口フラスコにテトラヒドロフラン250mlを入
れ、水素化アルミニウムリチウム4.10g(108mmol)を懸
濁させた。そこへ(2R,3R)−2,3−エポキシゲラニルゲ
ラニオール22.1g(72mmol)をテトラヒドロフラン50ml
に溶かした溶液を室温、15分間で滴下し、4時間還流し
た。反応物を0℃まで冷却し、水とテトラヒドロフラン
の1:1の溶液25mlを少しずつ加え、未反応の水素化アル
ミニウムリチウムをクエンチした後、3N−塩酸130mlを
加え、エーテル抽出した。抽出液を飽和食塩水で洗浄、
硫酸マグネシウムで乾燥後、溶媒を留去し、カラムクロ
マトグラフィーにより精製し、目的物20.3g(Y=92
%)を得た。
[Α] D 17 = + 4.81 ° (C = 2.9, CHCl 3 ), 95% een D 25 =
1.4887 ir (neat) cm -1 : 3400,2910,2850,1660,1440,1380,1025,
850 1 Hnmr (CCl 4 ) δ: 1.23 (3H, s), 1.57 (9H, s), 1.65 (3
H, s), 1.81 to 2.22 (12H, m), 2.84 (1H, t, J = 5.4Hz), 3.
60 (2H, d, J = 5.4Hz), 3.92 (1H, s), 4.77 to 5.23 (3H, b
m) 13 Cnmr (CDCl 3 ) δ: 15.71 (2C), 16.46, 17.33, 23.29, 2
5.35,26.32 (2C), 26.54,38.35,39.44 (2C), 60.89,63.
05,123.08,123.84,124.16,130.66,134.56,135.22 Example 2 (3R) -3,7,11,15-tetramethylhexadeca-6,10,14
-Triene-1,3-diol synthesis Equipped with a dropping funnel with a side tube, an arene cooling tube, and a nitrogen ball
250 ml of tetrahydrofuran was placed in a 500 cc three-necked flask, and 4.10 g (108 mmol) of lithium aluminum hydride was suspended. Thereto, 22.1 g (72 mmol) of (2R, 3R) -2,3-epoxygeranylgeraniol was added to 50 ml of tetrahydrofuran.
The solution dissolved in was added dropwise at room temperature for 15 minutes and refluxed for 4 hours. The reaction product was cooled to 0 ° C., 25 ml of a 1: 1 solution of water and tetrahydrofuran was added little by little to quench unreacted lithium aluminum hydride, 130 ml of 3N hydrochloric acid was added, and the mixture was extracted with ether. Wash the extract with saturated saline,
After drying over magnesium sulfate, the solvent was distilled off and the residue was purified by column chromatography to obtain 20.3 g of the desired product (Y = 92
%) Was obtained.

nD 25=1.4908 ir(neat)cm-1:3330,2910,1660,1440,1370,1020,880 nmr(CCl4)δ:1.17(3H,s),1.57(9H,s),1.63(3H,
s),1.37〜1.85(4H,m),1.85〜2.36(10H,m),3.76(2
H,d,J=6Hz),4.61(2H,s),4.87〜5.27(3H,bm) 実施例 3 (3R)−3−ヒドロキシ−3,7,11,15−テトラメチルヘ
キサデカ−6,10,14−トリエニルトシレートの合成 ソーダライム管を備えた200ccナス型フラスコ中、(3
R)−3,7,11,15−テトラメチルヘキサデカ−6,10,14−
トリエン−1,3−ジオール18.5g(60mmol)をピリジン20
mlに溶解し、0℃に冷却した。そこへp−トルエンスル
ホニルクロリド17.2g(90mmol)を加え、0℃、1.5時間
撹拌した後、氷水200mlを加え、塩化メチレン抽出し、2
0%硫酸、重曹水、飽和食塩水で洗浄、硫酸マグネシウ
ムで乾燥、溶媒留去して目的物26.5g(Y=95%)を得
た。これはTLC,NMRスペクトル、IRスペクトルにより純
粋であることを確認した。
n D 25 = 1.4908 ir (neat) cm -1 : 3330,2910,1660,1440,1370,1020,880 nmr (CCl 4 ) δ: 1.17 (3H, s), 1.57 (9H, s), 1.63 (3H ,
s), 1.37 ~ 1.85 (4H, m), 1.85 ~ 2.36 (10H, m), 3.76 (2
H, d, J = 6 Hz), 4.61 (2H, s), 4.87 to 5.27 (3H, bm) Example 3 (3R) -3-hydroxy-3,7,11,15-tetramethylhexadeca-6, Synthesis of 10,14-trienyl tosylate In a 200 cc eggplant-shaped flask equipped with a soda lime tube, (3
R) -3,7,11,15-tetramethylhexadeca-6,10,14-
18.5 g (60 mmol) of triene-1,3-diol was added to pyridine 20
It was dissolved in ml and cooled to 0 ° C. 17.2 g (90 mmol) of p-toluenesulfonyl chloride was added thereto, and the mixture was stirred at 0 ° C. for 1.5 hours, 200 ml of ice water was added, and the mixture was extracted with methylene chloride.
The extract was washed with 0% sulfuric acid, aqueous sodium hydrogen carbonate and saturated brine, dried over magnesium sulfate and the solvent was distilled off to obtain 26.5 g of the desired product (Y = 95%). It was confirmed to be pure by TLC, NMR spectrum and IR spectrum.

nD 25=1.5128 ir(neat)cm-1:3540,2930,1670,1600,1450,1360,1180,
1100,890 nmr(CCl4)δ:1.09(3H,s),1.56(9H,s),1.62(3H,
s),1.70〜1.81(4H,m),1.81〜2.27(10H,m),2.37(3
H,s),2.58(1H,s),4.08(2H,t,J=7Hz),4.80〜5.19
(3H,bm),7.22(2H,d,J=8Hz),7.66(2H,d,J=8Hz) 実施例 4 (3R)−3−ヒドロキシ−3,7,11,15−テトラメチルヘ
キサデカ−6,10,14−トリエニルイソプロピルスルフィ
300ccナス型フラスコにメタノール130mlを入れ、そこへ
金属ナトリウム1.5g(65mg−atom)を加えて溶解させ
た。イソプロピルメルカプタン4.95g(65mmol)を加
え、室温で10分間撹拌した。そこへ(3R)−3−ヒドロ
キシ−3,7,11,15−テトラメチルヘキサデカ−6,10,14−
トリエニルトシレート21.7g(47mmol)を100mlのメタノ
ールに溶かした溶液を滴下し、50℃、1時間撹拌した。
室温まで冷却してから200mlの水中に注ぎ、エーテル抽
出し、1N−水酸化ナトリウム水溶液、水、飽和食塩水で
洗浄、硫酸マグネシウムで乾燥した。溶媒留去後カラム
クロマトグラフィーで精製し、目的物15.1g(Y=84
%)を得た。
n D 25 = 1.5128 ir (neat) cm -1 : 3540,2930,1670,1600,1450,1360,1180,
1100,890 nmr (CCl 4 ) δ: 1.09 (3H, s), 1.56 (9H, s), 1.62 (3H,
s), 1.70 to 1.81 (4H, m), 1.81 to 2.27 (10H, m), 2.37 (3
H, s), 2.58 (1H, s), 4.08 (2H, t, J = 7Hz), 4.80-5.19
(3H, bm), 7.22 (2H, d, J = 8Hz), 7.66 (2H, d, J = 8Hz) Example 4 (3R) -3-hydroxy-3,7,11,15-tetramethylhexadeca -6,10,14-Trienyl isopropyl sulfide 130 ml of methanol was placed in a 300 cc eggplant-shaped flask, and 1.5 g (65 mg-atom) of metallic sodium was added and dissolved therein. 4.95 g (65 mmol) of isopropyl mercaptan was added, and the mixture was stirred at room temperature for 10 minutes. There (3R) -3-hydroxy-3,7,11,15-tetramethylhexadeca-6,10,14-
A solution of 21.7 g (47 mmol) of trienyl tosylate in 100 ml of methanol was added dropwise, and the mixture was stirred at 50 ° C for 1 hour.
After cooling to room temperature, it was poured into 200 ml of water, extracted with ether, washed with 1N-sodium hydroxide aqueous solution, water and saturated saline, and dried over magnesium sulfate. After distilling off the solvent, the residue was purified by column chromatography to obtain 15.1 g of the desired product (Y = 84
%) Was obtained.

nD 25=1.4978 ir(neat)cm-1:3440,2930,1660,1450,1380,9301 Hnmr(CCl4)δ:1.15(3H,s),1.25(6H,d,J=7Hz),
1.60(9H,s),1.66(3H,s),1.43〜1.88(4H,m),1.88
〜2.21(10H,m),2.37〜2.74(2H,m),2.63(1H,bs),
2.90(1H,hept,J=7Hz),4.78〜5.24(3H,bm) 実施例 5 (3R)−3−アセトキシ−3,7,11,15−テトラメチルヘ
キサデカ−6,10,14−トリエニルイソプロピルスルフィ
ドの合成 塩化カルシウム管を備えた250ccナス型フラスコに(3
R)−3−ヒドロキシ−3,7,11,15−テトラメチルヘキサ
デカ−6,10,14−トリエニルイソプロピルスルフィド14.
7g(40mmol)、無水酢酸45.9g(450mmol)、ピリジン3
5.6g(450mmol)、N,N−ジメチルアミノピリジン2.44g
(20mmol)を混合し、室温で18時間撹拌した。メタノー
ル30mlを加え、過剰の無水酢酸をクエンチした後、水35
0mlにあけ、エーテル抽出した。稀塩酸、飽和食塩水で
洗浄し、硫酸マグネシウムで乾燥した後、溶媒留去し、
カラムクロマトグラフィーで精製して目的物14.1g(Y
=87%)を得た。
n D 25 = 1.4978 ir (neat) cm -1 : 3440,2930,1660,1450,1380,930 1 Hnmr (CCl 4 ) δ: 1.15 (3H, s), 1.25 (6H, d, J = 7Hz),
1.60 (9H, s), 1.66 (3H, s), 1.43 to 1.88 (4H, m), 1.88
~ 2.21 (10H, m), 2.37 ~ 2.74 (2H, m), 2.63 (1H, bs),
2.90 (1H, hept, J = 7Hz), 4.78-5.24 (3H, bm) Example 5 (3R) -3-acetoxy-3,7,11,15-tetramethylhexadeca-6,10,14-tri Synthesis of enylisopropyl sulfide In a 250cc eggplant-shaped flask equipped with a calcium chloride tube (3
R) -3-Hydroxy-3,7,11,15-tetramethylhexadeca-6,10,14-trienylisopropyl sulfide 14.
7g (40mmol), acetic anhydride 45.9g (450mmol), pyridine 3
5.6 g (450 mmol), N, N-dimethylaminopyridine 2.44 g
(20 mmol) were mixed and stirred at room temperature for 18 hours. After adding 30 ml of methanol to quench excess acetic anhydride, water 35
It was poured into 0 ml and extracted with ether. After washing with dilute hydrochloric acid and saturated saline and drying over magnesium sulfate, the solvent was distilled off,
Purify by column chromatography 14.1 g (Y
= 87%).

〔α〕D 17=−2.49゜(C=3.0,CHCl3) nD 25=1.4917 ir(neat)cm-1:2920,1730,1660,1450,1360,12401 Hnmr(CCl4)δ:1.21(6H,d,J=6Hz),1.39(3H,s),
1.57(9H,s),1.65(3H,s),1.77〜2.40(14H,m),1.90
(3H,s),2.40〜2.70(2H,m),2.85(1H,hept,J=6H
z),4.78〜5.29(3H,bm) 実施例 6 (3′R)−2−(3′−アセトキシ−1′−イソプロ
ピルチオ−3′,7′,11′,15′−テトラメチルヘキサデ
カ−6′,10′,14′−トリエニル)−3,5,6−トリメチ
ルヒドロキノン−4−アセテートの合成 Y字管、温度計、塩化カルシウム管を備えた300cc四ツ
口フラスコ中、(3R)−3−アセトキシ−3,7,11,15−
テトラメチルヘキサデカ−6,10,14−トリエニルイソプ
ロピルスルフィド6.54g(16mmol)、4−アセトキシ−
2,3,5−トリメチルフェノール4.32g(48mmol)を塩化メ
チレン50mlに溶解し、更にs−コリジン2.30g(19mmo
l)を加え窒素置換した。この溶液を−50℃まで冷却
し、塩化スルフリル2.29g(17mmol)を加え、−50℃で1
0分間撹拌した。この溶液を−40℃に冷却したトリエチ
ルアミン9.31g(96mmol)の塩化メチレン50ml溶液に滴
下し、常法処理の後、カラムクロマトグラフィーで精製
して目的物4.90g(Y=51%)を得た。
[Α] D 17 = -2.49 ° (C = 3.0, CHCl 3 ) n D 25 = 1.4917 ir (neat) cm -1 : 2920,1730,1660,1450,1360,1240 1 Hnmr (CCl 4 ) δ: 1.21 (6H, d, J = 6Hz), 1.39 (3H, s),
1.57 (9H, s), 1.65 (3H, s), 1.77 to 2.40 (14H, m), 1.90
(3H, s), 2.40 to 2.70 (2H, m), 2.85 (1H, hept, J = 6H
z), 4.78-5.29 (3H, bm) Example 6 (3'R) -2- (3'-acetoxy-1'-isopropylthio-3 ', 7', 11 ', 15'-tetramethylhexadeca Synthesis of -6 ', 10', 14'-trienyl) -3,5,6-trimethylhydroquinone-4-acetate In a 300cc four-necked flask equipped with a Y-tube, thermometer, and calcium chloride tube, (3R) -3-acetoxy-3,7,11,15-
Tetramethylhexadeca-6,10,14-trienyl isopropyl sulfide 6.54 g (16 mmol), 4-acetoxy-
4.32 g (48 mmol) of 2,3,5-trimethylphenol was dissolved in 50 ml of methylene chloride, and 2.30 g of s-collidine (19 mmo
l) was added and the atmosphere was replaced with nitrogen. This solution was cooled to −50 ° C., 2.29 g (17 mmol) of sulfuryl chloride was added, and the mixture was stirred at −50 ° C. for 1 hour.
Stir for 0 minutes. This solution was added dropwise to a solution of 9.31 g (96 mmol) of triethylamine cooled in -40 ° C. in 50 ml of methylene chloride, and after normal treatment, purified by column chromatography to obtain 4.90 g of the desired product (Y = 51%). .

〔α〕D 17=−12.8゜(C=1.0,CHCl3) nD 25=1.5207 ir(neat)cm-1:3220,2920,1760,1730,1445,1360,1240,
12001 Hnmr(CDCl3)δ:1.09(3H,d,J=6Hz),1.23(3H,d,J
=6Hz),1.32(3H,s),1.58(9H,s),1.65(3H,s),1.8
2(3H,s),2.02(6H,s),2.14(3H,s),2.26(3H,s),
1.72〜3.00(15H,m),4.61(1H,t,J=6Hz),4.80〜5.30
(3H,bm),7.71(1H,s) mass m/e600(M+) 実施例 7 (3′R)−2−(3′アセトキシ−3′,7′,11′,1
5′−テトラメチル−6′,10′,14′−ヘキサデカトリ
エニル)−3,5,6−トリメチルヒドロキノン−4−アセ
テートの合成 アリーン冷却器、塩化カルシウム管を備えた50ml二ツ口
フラスコにエタノール20ml、ラネーニッケル(W4)8.8g
を加え、15分間還流した後に室温まで冷却し、(3′
R)−2−(3′−アセトキシ−1′−イソプロピルチ
オ−3′,7′,11′,15′−テトラメチルヘキサデカ−
6′,10′,14′−トリエニル)−3,5,6−トリメチルヒ
ドロキノン−4−アセテート1.00g(1.67mmol)をエタ
ノール10mlに溶かした溶液を加えて室温で1時間撹拌
し、更に30℃で2.5時間撹拌した。そしてセライトを通
して触媒を濾過し、溶媒を留去した後目的の脱硫体840m
g(Y=95%)を得た。これはTLC,1H−NMR,IRスペクト
ルにより純品であることを確認した。
[Α] D 17 = -12.8 ° (C = 1.0, CHCl 3 ) n D 25 = 1.5207 ir (neat) cm -1 : 3220,2920,1760,1730,1445,1360,1240,
1200 1 Hnmr (CDCl 3 ) δ: 1.09 (3H, d, J = 6Hz), 1.23 (3H, d, J
= 6Hz), 1.32 (3H, s), 1.58 (9H, s), 1.65 (3H, s), 1.8
2 (3H, s), 2.02 (6H, s), 2.14 (3H, s), 2.26 (3H, s),
1.72 to 3.00 (15H, m), 4.61 (1H, t, J = 6Hz), 4.80 to 5.30
(3H, bm), 7.71 (1H, s) mass m / e600 (M + ) Example 7 (3'R) -2- (3'acetoxy-3 ', 7', 11 ', 1
Synthesis of 5'-tetramethyl-6 ', 10', 14'-hexadecatrienyl) -3,5,6-trimethylhydroquinone-4-acetate 20 ml ethanol, Raney nickel (W4) 8.8 g in a 50 ml two-necked flask equipped with an arene condenser and a calcium chloride tube.
Was added, the mixture was refluxed for 15 minutes, then cooled to room temperature, and (3 '
R) -2- (3'-acetoxy-1'-isopropylthio-3 ', 7', 11 ', 15'-tetramethylhexadeca-
A solution of 1.00 g (1.67 mmol) of 6 ', 10', 14'-trienyl) -3,5,6-trimethylhydroquinone-4-acetate in 10 ml of ethanol was added, and the mixture was stirred at room temperature for 1 hour, and further 30 ° C. The mixture was stirred for 2.5 hours. Then, the catalyst was filtered through Celite and the solvent was distilled off.
g (Y = 95%) were obtained. It was confirmed to be pure by TLC, 1 H-NMR, and IR spectrum.

〔α〕D 23=+15.8゜(C=2.3,CHCl3) ir(neat)cm-1:3480,2930,1760,1730,1220,1075,8401 Hnmr(CCl4)δ:1.43(3H,s),1.58(9H,s),1.63(3
H,s),1.97(12H,s),2.23(3H,s),1.58〜2.34(16H,
m),5.03(3H,bm),5.35(1H,s) 実施例 8 d−α−トコトリエノールの合成 温度計、窒素球を備えた50ml四ツ口フラスコにエーテル
15mlを入れ、そこへ水素化アルミニウムリチウム153mg
(4.0mmol)を加えて懸濁させた。これを5℃に冷却
し、(3′R)−2−(3′−アセトキシ−3′,7′,1
1′,15′−テトラメチル−6′,10′,14′−ヘキサデカ
トリエニル)−3,5,6−トリメチルヒドロキノン−4−
アセテート350mg(0.66mmol)をエーテル7mlに溶かした
溶液を滴下した後室温で1時間撹拌した。そして0℃ま
で冷却してから水2mlを少しずつ加えて過剰の水素化リ
チウムアルミニウムをクエンチした。3N−塩酸15mlを加
えて有機層を分離した後エーテルを抽出し、先に分離し
た有機層と合わせてチオ硫酸ナトリウム水溶液、飽和食
塩水で洗浄してから硫酸ナトリウムで乾燥後エーテルを
留去し、目的の粗生成物295mgを得た。これはこのまま
次の反応に用いた。
[Α] D 23 = + 15.8 ° (C = 2.3, CHCl 3 ) ir (neat) cm -1 : 3480,2930,1760,1730,1220,1075,840 1 Hnmr (CCl 4 ) δ: 1.43 (3H , s), 1.58 (9H, s), 1.63 (3
H, s), 1.97 (12H, s), 2.23 (3H, s), 1.58 to 2.34 (16H,
m), 5.03 (3H, bm), 5.35 (1H, s) Example 8 Synthesis of d-α-tocotrienol Ether in a 50 ml four-necked flask equipped with a thermometer and nitrogen bulb.
Put 15 ml, and 153 mg of lithium aluminum hydride
(4.0 mmol) was added and suspended. It is cooled to 5 ° C. and (3′R) -2- (3′-acetoxy-3 ′, 7 ′, 1
1 ', 15'-Tetramethyl-6', 10 ', 14'-hexadecatrienyl) -3,5,6-trimethylhydroquinone-4-
A solution of 350 mg (0.66 mmol) of acetate in 7 ml of ether was added dropwise, and the mixture was stirred at room temperature for 1 hour. Then, after cooling to 0 ° C., 2 ml of water was added little by little to quench excess lithium aluminum hydride. 3N-hydrochloric acid (15 ml) was added to separate the organic layer, and then ether was extracted.The organic layer was separated, washed with an aqueous sodium thiosulfate solution and saturated saline, dried over sodium sulfate, and then the ether was distilled off. , 295 mg of the target crude product was obtained. This was used as it was in the next reaction.

アリーン冷却器、窒素球を備えた50ml二ツ口フラスコに
粗生成物(脱アセチル体)295mg、ベンゼン10mlを入
れ、p−トルエンスルホン酸一水塩14mg(0.07mmol)を
加えた後、70℃で30分間撹拌した。これに水10mlを加え
て有機層を分離し、水層をエーテル抽出して先の有機層
と合わせる。これを飽和炭酸水素ナトリウム水溶液、飽
和食塩水で洗浄し、硫酸マグネシウムで乾燥後、溶媒を
留去して目的の粗生成物299mgを得た。これをカラムク
ロマトグラフィー(シリカゲル20g)で精製してd−α
−トコトリエノール251mg(Y=89%)を得た。
After placing 295 mg of the crude product (deacetylated product) and 10 ml of benzene in a 50 ml two-necked flask equipped with an arene condenser and a nitrogen bulb, 14 mg (0.07 mmol) of p-toluenesulfonic acid monohydrate was added, and then 70 ° C. And stirred for 30 minutes. 10 ml of water was added to this to separate the organic layer, and the aqueous layer was extracted with ether and combined with the previous organic layer. This was washed with saturated aqueous sodium hydrogen carbonate solution and saturated brine, dried over magnesium sulfate, and the solvent was evaporated to give the desired crude product (299 mg). This was purified by column chromatography (silica gel 20 g) to give d-α.
251 mg (Y = 89%) of tocotrienols were obtained.

〔α〕D 20=−5.14゜(C=0.35,CHCl3),90%eemass m
/e424(M+) ir(neat)cm-1:3450,2930,1255,1215,1165,1085,8551 Hnmr(CDCl3)δ:1.26(3H,s),1.59(9H,s),1.68(3
H,s),1.80(2H,t,J=7Hz),2.00(3H,s),2.11(3H,
s),2.16(3H,s),2.00〜2.16(12H,m),2.61(2H,t,J
=7Hz),4.18(1H,s),5.13(3H,bm)
[Α] D 20 = -5.14 ° (C = 0.35, CHCl 3 ), 90% eemass m
/ e424 (M + ) ir (neat) cm -1 : 3450,2930,1255,1215,1165,1085,855 1 Hnmr (CDCl 3 ) δ: 1.26 (3H, s), 1.59 (9H, s), 1.68 (3
H, s), 1.80 (2H, t, J = 7Hz), 2.00 (3H, s), 2.11 (3H,
s), 2.16 (3H, s), 2.00 to 2.16 (12H, m), 2.61 (2H, t, J
= 7Hz), 4.18 (1H, s), 5.13 (3H, bm)

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】構造式: (式中R1は式 で表される基を意味する) で表されるゲラニルゲラニオールをエナンシオセレクテ
ィブ・オキシデーション(enantio−selective oxidati
on)を行い、 構造式: で表されるエポキシ体を得、次いで該化合物を還元的に
開裂せしめ、 構造式: で示される化合物を得、次いで該化合物をトシル化し
て、 構造式: 〔式中Tsはトシル基 を表す。以下同様〕 で表される化合物を得、次いで該化合物を金属ナトリウ
ムの存在下イソプロピルメルカプタンと反応させて、 構造式: で表される化合物を得、次いで該化合物をアセチル化し
て、 構造式: (式中Acはアセチル基を示す。以下同様) で表される化合物を得、次いで該化合物を4−アセトキ
シ−2,3,5−トリメチルフェノールと反応させて、 構造式: で表される化合物を得、次いで該化合物をラネーニッケ
ルと反応させ、更に脱アセチル化して、 構造式: で表される化合物を得、次いで該化合物を直接環化せし
めるか、又は酸化してキノン体を得た後に環化せしめる
ことを特徴とする、 構造式: で表される光学活性d−α−トコトリエノールの製造方
法。
1. A structural formula: (Where R 1 is the formula The geranylgeraniol represented by is represented by the enantio-selective oxidati
on) and the structural formula: An epoxy compound represented by the following formula is obtained, and then the compound is reductively cleaved to obtain a structural formula: A compound represented by the formula: [In the formula, Ts is a tosyl group Represents The same applies to the following], and then the compound is reacted with isopropyl mercaptan in the presence of metallic sodium to give a structural formula: A compound represented by the following formula is obtained, and then the compound is acetylated to obtain the structural formula: (Wherein Ac represents an acetyl group; the same applies hereinafter), and then the compound is reacted with 4-acetoxy-2,3,5-trimethylphenol to give a structural formula: A compound represented by the following formula is obtained, and then the compound is reacted with Raney nickel and further deacetylated to obtain a structural formula: The compound represented by the formula (1) is obtained, and then the compound is directly cyclized, or is oxidized to obtain a quinone body and then cyclized, and the structural formula: The manufacturing method of optically active d- (alpha) -tocotrienol represented by these.
JP20653286A 1986-09-02 1986-09-02 Process for producing optically active α-tocotrienol Expired - Lifetime JPH0788376B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP20653286A JPH0788376B2 (en) 1986-09-02 1986-09-02 Process for producing optically active α-tocotrienol

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP20653286A JPH0788376B2 (en) 1986-09-02 1986-09-02 Process for producing optically active α-tocotrienol

Publications (2)

Publication Number Publication Date
JPS6363674A JPS6363674A (en) 1988-03-22
JPH0788376B2 true JPH0788376B2 (en) 1995-09-27

Family

ID=16524928

Family Applications (1)

Application Number Title Priority Date Filing Date
JP20653286A Expired - Lifetime JPH0788376B2 (en) 1986-09-02 1986-09-02 Process for producing optically active α-tocotrienol

Country Status (1)

Country Link
JP (1) JPH0788376B2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6531303B1 (en) 1998-07-06 2003-03-11 Arkion Life Sciences Llc Method of producing geranylgeraniol
US6410755B1 (en) 1998-07-06 2002-06-25 Dcv, Inc. Method of vitamin production
EP1095033A1 (en) 1998-07-06 2001-05-02 Eastman Chemical Company Method of producing vitamin e
WO2005035490A2 (en) 2003-10-10 2005-04-21 Yasoo Health, Inc. PROCESS FOR SYNTHESIZING d-TOCOTRIENOLS
CA2996149A1 (en) 2005-06-01 2006-12-07 Bioelectron Technology Corporation Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
JP5374162B2 (en) 2006-02-22 2013-12-25 エジソン ファーマシューティカルズ, インコーポレイテッド Modulation of redox-activated therapeutic side chain variants and energy biomarkers for the treatment of mitochondrial diseases and other conditions
MX363223B (en) 2008-09-10 2019-03-15 Bioelectron Tech Corp Treatment of pervasive developmental disorders with redox-active therapeutics.
WO2010051277A1 (en) 2008-10-28 2010-05-06 Edison Pharmaceuticals, Inc. Process for the production of alpha-tocotrienol and derivatives
EP2424495B1 (en) 2009-04-28 2018-01-17 Bioelectron Technology Corporation Treatment of leber's hereditary optic neuropathy and dominant optic atrophy with tocotrienol quinones
BRPI1011776A2 (en) 2009-06-25 2018-03-13 Ampere Life Sciences Inc treatment of pervasive developmental disorder with tocotrienols or trienol enriched extracts
US10745371B2 (en) 2015-12-16 2020-08-18 Ptc Therapeutics, Inc. Methods for enriching alpha-tocotrienol from mixed tocol compositions
CA3008849A1 (en) 2015-12-17 2017-06-22 Bioelectron Technology Corporation Flouroalkyl, flouroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders

Also Published As

Publication number Publication date
JPS6363674A (en) 1988-03-22

Similar Documents

Publication Publication Date Title
JP6980648B2 (en) Production of 3-hydroxy-3,6-dimethylhexahydrobenzofuran-2-one and its derivatives
JPH0788376B2 (en) Process for producing optically active α-tocotrienol
HU207288B (en) Process for enenthioselective producing phenyl-isoserine derivatives
JPH05502232A (en) Method for producing sclareolide
US5773629A (en) Synthesis of (4S, 5R) -2, 4-diphenyl-5-carboxy-oxazoline derivative as taxol side-chain precursor
JP2685785B2 (en) Method for producing optically active α-tocotrienol
Murayama et al. Syntheses of natural (-)-osmundalactone and its epimer
JP3086738B2 (en) Method for producing high-purity tocopheryl retinoate
US4958037A (en) Precursors and synthesis of methyl-9-oxo-11α, 16-dihydroxy-16-vinyl-5-cis-13-trans-prostadienoates
EP0003221B1 (en) Process for the manufacture of 3,4-dihydro-benzopyran derivatives and starting materials in this process
JP3756266B2 (en) Method for producing optically active α-ionone
JPH0745504B2 (en) Prostaglandin precursor and process for producing the same
JP2756790B2 (en) Method for producing optically active cyclopentenol derivative
JP3987285B2 (en) Synthesis of 3,4-dihydroxybutanoic acid and derivatives from substituted pentoses
JPH0780869B2 (en) Method for producing (2R) -6-hydroxy-2- (4-methyl-3-pentenyl) -2,5,7,8-tetramethylchroman
US3652603A (en) Method for production of 2 3-di(lower alkoxy)-5-methyl-1 4-benzoquinone
Hayashi et al. A Diastereocontrolled Route to (R)-(-)-Baclofen Using a Cyclopentanoid Chiral Building Block
EP0213313A2 (en) Precursors and synthesis of methyl-9-oxo-11 alpha, 16-dihydroxy-16-vinyl-5-cis-13-trans prostadienoates
JPS63174960A (en) Lactic acid derivative
CN118084963A (en) Preparation method of prostaglandin intermediate protected by silicon reagent
JP2718546B2 (en) Stereoselective production of cyclopentenone derivatives
US4074045A (en) 2H-cyclopenta b!furan-2-ones and process for preparation
JPH0641460B2 (en) Method for producing α, β-epoxy aldehyde
JPS5833858B2 (en) Method for producing sesquiterpene derivatives
JPS63174957A (en) Production of 4-amino-3-hydroxylactic acid